Location: Home
  • search
  • go
  • Relate News
  • 7/19/2019Novartis Wins Chinese Approval of MS Drug Gilenya
  • 7/19/2019CDE Seeks Feedbacks on Implementation Suggestions for Transformation o...
  • 7/19/2019Cross-sector Synergy: China Innovation at Merck
  • 7/18/2019Alphamab Oncology Files IPO at HKEX
  • 7/18/2019U.S. Targeting of Chinese Scientists Fuels a Brain Drain
  • 7/18/2019State Council Issues Policy to Establish Inspection Forces for Drug Sa...
  • 7/18/2019Snapshot of BMI System Financial Performance in Q2/2019
  • 7/18/2019SMEI Releases Rankings of Top 100 Chinese Retail Pharmacy Chains in 20...
  • 7/17/201960% of 135 Listed Biopharma Companies Issued Positive H1 Performance G...
  • 7/17/2019China Daily: Latest Healthy China Guideline Targets Chronic Illnesses
  • 7/16/2019SMEI President Reviews Pharma Industry Performance with Lowered Growth...
  • 7/16/2019SMEI Releases Ranking of Top 100 Chinese Biopharma Companies in 2018
  • 7/16/2019Chinese Biopharma Startups Raised $1,645M and Launched Seven IPOs in H...
  • 7/16/2019Luye Pharma's Transdermal Patch Receives German Medical Regulatory App...
  • 7/16/2019Trade War and China's Changing Trade Mark Law
  • 7/15/2019State Council Issues the Action Plan for Healthy China Initiative
  • 7/15/2019Central Government Urges to Enhanced Basic Medical Care for Impoverish...
  • 7/15/2019SinoMab Files IPO in Hong Kong, Making It the First Homegrown Biotech ...
  • 7/12/2019Recent Executive Moves
  • 7/12/2019Takeda Files NDA for Entyvio (Vedolizumab) in China
  • 7/12/2019Novartis Files NDA for Second Indication of Dabrafenib/Trametinib in C...
  • 7/10/2019MacroGenics and I-Mab Announce Collaboration and License Agreement for...
  • 7/10/2019China NT Pharma Group To Buy 40% Stake In Hong Kong WD Pharma
  • 7/10/2019SAMR Releases Draft Regulation for Serious Violations and Bad Credits
  • 7/10/2019NHC: All Poor Rural Areas to Get Basic Healthcare Access
  • 7/9/2019IQVIA: Chinese Hospital Drug Market Up 4.3% in MAT Q1/2019
  • 7/9/2019Priority Review Granted to BeiGene’s Supplemental NDA in China for Ti...
  • 7/9/2019Trade Tensions Undermines Flow of Chinese VC to US Biotechs
  • 7/9/2019Fosun Pharma Picks Up GSK Plant in China along with Rights to Make Epi...
  • 7/8/2019Pfizer Launches Anticancer VIZIMPRO (dacomitinib) following Chinese A...
  • Page:113/334 Total number of articles:9998: [First][<<] [111] [112] [113] [114] [115] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group